Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils

Neutrophilic panniculitis is an infrequent but characteristic adverse event under therapy with BRAF inhibitors (BRAFi). Since the approval of vemurafenib for treatment of metastatic melanoma in 2011, only two cases of neutrophilic panniculitis in malignancies other than melanoma have been published....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Ther
Main Authors: Richarz, Nina Anika, Puig, Luis, Pérez, Noelia, Cuadra-Urteaga, Jose, Elez, Elena, Fernández-Figueras, Maria Teresa
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Bedside to Bench Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370375/
https://ncbi.nlm.nih.gov/pubmed/30426827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados